Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Pharmacology|July 30, 2019
Potential for Nuclear Medicine Therapy for Glioblastoma TreatmentClément Bailly, Aurelien Vidal, Coralie Bonnemaire, et al.
Scientific Reports|September 2, 2017
FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomasArarat Chakhoyan, Jean-Sebastien Guillamo, Solène Collet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, 18F-FMISO PET, and 18F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed GlioblastomaSolène Collet, Jean-Sébastien Guillamo, David Hassanein Berro, et al.
Frontiers in Medicine|June 29, 2019
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of GliomaMichael Gérard, Aurélien Corroyer-Dulmont, Paul Lesueur, et al.
EJNMMI Research|November 25, 2023
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [64Cu][Cu(ATSM)] PET and proteomic studiesJade Fantin, Jérôme Toutain, Elodie A Pérès, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|August 7, 2016
Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma modelsArarat Chakhoyan, Aurélien Corroyer-Dulmont, Marine M Leblond, et al.
Neuro-Oncology|September 21, 2019
VCAM-1 targeted alpha-particle therapy for early brain metastasesAurélien Corroyer-Dulmont, Samuel Valable, Nadia Falzone, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2017
[18F]-FMISO PET study of hypoxia in gliomas before surgery: correlation with molecular markers of hypoxia and angiogenesisLien Bekaert, Samuel Valable, Emmanuèle Lechapt-Zalcman, et al.
Frontiers in Oncology|September 10, 2021
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of ChoiceAurélien Corroyer-Dulmont, Cyril Jaudet, Anne-Marie Frelin, et al.
Radiation Oncology (London, England)|January 29, 2025
Neurocognitive impact of different irradiation modalities for patients with grade I-II skull base meningioma: a prospective multi-arm cohort study (CANCER COG)Paul Lesueur, Florence Joly, Benedicte Clarisse, et al.
Pageof 11